Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer
Xuan Jiang, Weihua Li, Xiaoying Li, Huimin Bai, Zhenyu ZhangDepartment of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of ChinaAbstract: Poly (ADP-ribose) polymerase (PARP) inhibitors are a class of targeted agents for the treatm...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Dove Medical Press
2019-05-01
|
| Rangatū: | Cancer Management and Research |
| Ngā marau: | |
| Urunga tuihono: | https://www.dovepress.com/current-status-and-future-prospects-of-parp-inhibitor-clinical-trials--peer-reviewed-article-CMAR |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|